NCT00367536View on ClinicalTrials.gov

Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Postmenopause
Interventions
DRUG

bazedoxifene/conjugated estrogens combination tablet

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00367536 - Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution | Biotech Hunter | Biotech Hunter